Spesolimab use in treatment of pyoderma gangrenosum
Uloženo v:
| Vydáno v: | JAAD Case Reports Ročník 34; s. 18 - 22 |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
Elsevier Inc
01.04.2023
Elsevier |
| Témata: | |
| ISSN: | 2352-5126, 2352-5126 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Author | Lebwohl, Mark G. Khattri, Saakshi Guénin, Sophie H. |
|---|---|
| Author_xml | – sequence: 1 givenname: Sophie H. surname: Guénin fullname: Guénin, Sophie H. email: Sophiehelene.guenin@gmail.com – sequence: 2 givenname: Saakshi surname: Khattri fullname: Khattri, Saakshi – sequence: 3 givenname: Mark G. surname: Lebwohl fullname: Lebwohl, Mark G. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36936866$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFUk1v1DAQjVARLaV_gAPKkcsu_kgcByEqVFGoVIlD4TxyJpPFIbEXO6m0_x6n26K2EuVkyzPvPc-89zI7cN5Rlr3mbM0ZV-_6dd9iWAsm5JrxNRPiWXYkZClWJRfq4N79MDuJsWeM8bKoZMVfZIdS1VJppY4yebWl6Ac7miafI-XW5VMgM43kptx3-XbnWwqjyTfGbQI5H-fxVfa8M0Okk9vzOPtx_vn72dfV5bcvF2efLldYFlKsaq3RCN5JwqrlpmSacYnUYNMR1lzqjou6kIqj7GSRam0jK2Sq5Q1rO9TyOLvY87be9LAN6ZNhB95YuHnwYQMmTBYHgqrplK606DTqQjbUsEYbQwxLxbASdeI63XNt52akFtN4wQwPSB9WnP0JG38NfNkb5yIxvL1lCP73THGC0UakYTCO_BxBVFpXda0ES61v7ov9Vblbe2rQ-wYMPsZAHaCdzGT9om2HJAqLydDDYjIsJgPjkExOUPEIesf-JOjDHkTJrmtLASJackitDYRT2qd9Gv7xERwH6yya4RftKPZ-Di4FAThEAQyulugtyRMypU4Wy7zv_03wP_U_-dvn4g |
| CitedBy_id | crossref_primary_10_1016_j_jaad_2024_01_034 crossref_primary_10_3390_biom15060817 crossref_primary_10_3390_ijms25042440 crossref_primary_10_1080_1744666X_2023_2298356 crossref_primary_10_1177_2050313X241235451 crossref_primary_10_1016_j_jaad_2025_08_084 crossref_primary_10_1007_s00403_024_03689_4 crossref_primary_10_1016_j_det_2023_12_002 crossref_primary_10_1016_j_jaad_2023_03_007 crossref_primary_10_1016_j_jaad_2023_12_077 crossref_primary_10_1001_jamadermatol_2024_4342 crossref_primary_10_1080_17512433_2024_2447776 crossref_primary_10_1111_ijd_17088 crossref_primary_10_1038_s41467_024_54559_6 crossref_primary_10_3389_fimmu_2024_1481192 crossref_primary_10_1111_1346_8138_17028 crossref_primary_10_1016_j_jid_2024_09_023 crossref_primary_10_3389_fimmu_2025_1581996 crossref_primary_10_7759_cureus_64474 crossref_primary_10_1111_ijd_16941 |
| Cites_doi | 10.1016/j.celrep.2015.12.072 10.1111/j.1365-2133.2007.08212.x 10.1007/s40257-017-0251-7 10.1016/j.jaad.2019.08.001 10.1136/gut.2005.074815 10.1038/jid.2011.234 10.1111/bjd.20967 10.1111/bjd.14037 10.1056/NEJMoa2111563 10.3389/fimmu.2019.02532 |
| ContentType | Journal Article |
| Copyright | 2023 American Academy of Dermatology, Inc. American Academy of Dermatology, Inc. 2023 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. This is an open access.. 2023 American Academy of Dermatology, Inc. |
| Copyright_xml | – notice: 2023 American Academy of Dermatology, Inc. – notice: American Academy of Dermatology, Inc. – notice: 2023 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. This is an open access.. 2023 American Academy of Dermatology, Inc. |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1016/j.jdcr.2023.01.022 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2352-5126 |
| EndPage | 22 |
| ExternalDocumentID | oai_doaj_org_article_7bf68782f8c843beb0b8aae0c560c729 PMC10015112 36936866 10_1016_j_jdcr_2023_01_022 S2352512623000346 1_s2_0_S2352512623000346 |
| Genre | Case Reports |
| GroupedDBID | .1- .FO 0R~ 1P~ 4.4 457 53G 5VS AAEDT AAEDW AAIKJ AALRI AAXUO AAYWO ABMAC ACGFS ACVFH ADBBV ADCNI ADEZE ADVLN AEUPX AEXQZ AFJKZ AFPUW AFRHN AFTJW AGHFR AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS APXCP BAWUL BCNDV EBS EJD FDB GROUPED_DOAJ HYE IPNFZ IXB KQ8 M41 M~E O9- OK1 RIG ROL RPM SSZ Z5R 0SF 6I. AACTN AAFTH AFCTW NCXOZ ABMYL AAYXX CITATION NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c5432-988ca21f3ec7d1a508013cebcbfec9138f1294361c3f34013db37c06d1b0dfc83 |
| IEDL.DBID | DOA |
| ISSN | 2352-5126 |
| IngestDate | Fri Oct 03 12:42:57 EDT 2025 Thu Aug 21 18:37:36 EDT 2025 Fri Sep 05 10:57:00 EDT 2025 Mon Jul 21 05:32:39 EDT 2025 Thu Nov 13 04:28:38 EST 2025 Tue Nov 18 22:30:32 EST 2025 Sat Mar 16 16:14:11 EDT 2024 Tue Feb 25 20:12:40 EST 2025 Tue Aug 26 16:31:59 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | dermatology spesolimab IL biologics pyoderma gangrenosum GPP PG pathergy generalized pustular psoriasis interleukin IL, interleukin GPP, generalized pustular psoriasis PG, pyoderma gangrenosum |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5432-988ca21f3ec7d1a508013cebcbfec9138f1294361c3f34013db37c06d1b0dfc83 |
| Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
| OpenAccessLink | https://doaj.org/article/7bf68782f8c843beb0b8aae0c560c729 |
| PMID | 36936866 |
| PQID | 2788799620 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_7bf68782f8c843beb0b8aae0c560c729 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10015112 proquest_miscellaneous_2788799620 pubmed_primary_36936866 crossref_citationtrail_10_1016_j_jdcr_2023_01_022 crossref_primary_10_1016_j_jdcr_2023_01_022 elsevier_sciencedirect_doi_10_1016_j_jdcr_2023_01_022 elsevier_clinicalkeyesjournals_1_s2_0_S2352512623000346 elsevier_clinicalkey_doi_10_1016_j_jdcr_2023_01_022 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-04-01 |
| PublicationDateYYYYMMDD | 2023-04-01 |
| PublicationDate_xml | – month: 04 year: 2023 text: 2023-04-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | JAAD Case Reports |
| PublicationTitleAlternate | JAAD Case Rep |
| PublicationYear | 2023 |
| Publisher | Elsevier Inc Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier |
| References | Xu, Balgobind, Strunk, Garg, Alloo (bib2) 2020; 83 Carrier, Ma, Ramon (bib10) 2011; 131 Kolios, Maul, Meier (bib5) 2015; 173 Alavi, French, Davis, Brassard, Kirsner (bib3) 2017; 18 Pomerantz, Husni, Mody, Qureshi (bib8) 2007; 157 Henry, Sullivan, Clancy, Afonina, Kulms, Martin (bib4) 2016; 14 Tan, Gordon, Lebwohl, George, Lebwohl (bib6) 2001; 137 Min, Kus, Wei (bib1) 2022; 186 Brooklyn, Dunnill, Shetty (bib7) 2006; 55 Bachelez, Choon, Marrakchi (bib9) 2021; 385 Yuan, Xu, Liu, Liu, Huang, Su (bib11) 2019; 10 Xu (10.1016/j.jdcr.2023.01.022_bib2) 2020; 83 Kolios (10.1016/j.jdcr.2023.01.022_bib5) 2015; 173 Pomerantz (10.1016/j.jdcr.2023.01.022_bib8) 2007; 157 Alavi (10.1016/j.jdcr.2023.01.022_bib3) 2017; 18 Bachelez (10.1016/j.jdcr.2023.01.022_bib9) 2021; 385 Brooklyn (10.1016/j.jdcr.2023.01.022_bib7) 2006; 55 Yuan (10.1016/j.jdcr.2023.01.022_bib11) 2019; 10 Tan (10.1016/j.jdcr.2023.01.022_bib6) 2001; 137 Min (10.1016/j.jdcr.2023.01.022_bib1) 2022; 186 Carrier (10.1016/j.jdcr.2023.01.022_bib10) 2011; 131 Henry (10.1016/j.jdcr.2023.01.022_bib4) 2016; 14 |
| References_xml | – volume: 137 start-page: 930 year: 2001 end-page: 933 ident: bib6 article-title: Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody publication-title: Arch Dermatol – volume: 385 start-page: 2431 year: 2021 end-page: 2440 ident: bib9 article-title: Trial of spesolimab for generalized pustular psoriasis publication-title: N Engl J Med – volume: 157 start-page: 1274 year: 2007 end-page: 1275 ident: bib8 article-title: Adalimumab for treatment of pyoderma gangrenosum publication-title: Br J Dermatol – volume: 10 start-page: 2532 year: 2019 ident: bib11 article-title: Biology of IL-36 signaling and its role in systemic inflammatory diseases publication-title: Front Immunol – volume: 83 start-page: 425 year: 2020 end-page: 429 ident: bib2 article-title: Prevalence estimates for pyoderma gangrenosum in the United States: an age- and sex-adjusted population analysis publication-title: J Am Acad Dermatol – volume: 18 start-page: 355 year: 2017 end-page: 372 ident: bib3 article-title: Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment publication-title: Am J Clin Dermatol – volume: 55 start-page: 505 year: 2006 end-page: 509 ident: bib7 article-title: Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial publication-title: Gut – volume: 186 start-page: 1035 year: 2022 end-page: 1037 ident: bib1 article-title: Evaluating the role of histopathology in diagnosing pyoderma gangrenosum using Delphi and PARACELSUS criteria: a multicentre, retrospective cohort study publication-title: Br J Dermatol – volume: 14 start-page: 708 year: 2016 end-page: 722 ident: bib4 article-title: Neutrophil-derived proteases escalate inflammation through activation of IL-36 family cytokines publication-title: Cell Rep – volume: 173 start-page: 1216 year: 2015 end-page: 1223 ident: bib5 article-title: Canakinumab in adults with steroid-refractory pyoderma gangrenosum publication-title: Br J Dermatol – volume: 131 start-page: 2428 year: 2011 end-page: 2437 ident: bib10 article-title: Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis publication-title: J Invest Dermatol – volume: 14 start-page: 708 issue: 4 year: 2016 ident: 10.1016/j.jdcr.2023.01.022_bib4 article-title: Neutrophil-derived proteases escalate inflammation through activation of IL-36 family cytokines publication-title: Cell Rep doi: 10.1016/j.celrep.2015.12.072 – volume: 157 start-page: 1274 issue: 6 year: 2007 ident: 10.1016/j.jdcr.2023.01.022_bib8 article-title: Adalimumab for treatment of pyoderma gangrenosum publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2007.08212.x – volume: 18 start-page: 355 issue: 3 year: 2017 ident: 10.1016/j.jdcr.2023.01.022_bib3 article-title: Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment publication-title: Am J Clin Dermatol doi: 10.1007/s40257-017-0251-7 – volume: 83 start-page: 425 issue: 2 year: 2020 ident: 10.1016/j.jdcr.2023.01.022_bib2 article-title: Prevalence estimates for pyoderma gangrenosum in the United States: an age- and sex-adjusted population analysis publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2019.08.001 – volume: 55 start-page: 505 issue: 4 year: 2006 ident: 10.1016/j.jdcr.2023.01.022_bib7 article-title: Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial publication-title: Gut doi: 10.1136/gut.2005.074815 – volume: 131 start-page: 2428 issue: 12 year: 2011 ident: 10.1016/j.jdcr.2023.01.022_bib10 article-title: Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis publication-title: J Invest Dermatol doi: 10.1038/jid.2011.234 – volume: 186 start-page: 1035 issue: 6 year: 2022 ident: 10.1016/j.jdcr.2023.01.022_bib1 article-title: Evaluating the role of histopathology in diagnosing pyoderma gangrenosum using Delphi and PARACELSUS criteria: a multicentre, retrospective cohort study publication-title: Br J Dermatol doi: 10.1111/bjd.20967 – volume: 173 start-page: 1216 issue: 5 year: 2015 ident: 10.1016/j.jdcr.2023.01.022_bib5 article-title: Canakinumab in adults with steroid-refractory pyoderma gangrenosum publication-title: Br J Dermatol doi: 10.1111/bjd.14037 – volume: 385 start-page: 2431 issue: 26 year: 2021 ident: 10.1016/j.jdcr.2023.01.022_bib9 article-title: Trial of spesolimab for generalized pustular psoriasis publication-title: N Engl J Med doi: 10.1056/NEJMoa2111563 – volume: 137 start-page: 930 issue: 7 year: 2001 ident: 10.1016/j.jdcr.2023.01.022_bib6 article-title: Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody publication-title: Arch Dermatol – volume: 10 start-page: 2532 year: 2019 ident: 10.1016/j.jdcr.2023.01.022_bib11 article-title: Biology of IL-36 signaling and its role in systemic inflammatory diseases publication-title: Front Immunol doi: 10.3389/fimmu.2019.02532 |
| SSID | ssj0001547371 |
| Score | 2.362585 |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 18 |
| SubjectTerms | biologics Case Report Dermatology pathergy pyoderma gangrenosum spesolimab |
| Title | Spesolimab use in treatment of pyoderma gangrenosum |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2352512623000346 https://www.clinicalkey.es/playcontent/1-s2.0-S2352512623000346 https://dx.doi.org/10.1016/j.jdcr.2023.01.022 https://www.ncbi.nlm.nih.gov/pubmed/36936866 https://www.proquest.com/docview/2788799620 https://pubmed.ncbi.nlm.nih.gov/PMC10015112 https://doaj.org/article/7bf68782f8c843beb0b8aae0c560c729 |
| Volume | 34 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: Directory of Open Access Journals customDbUrl: eissn: 2352-5126 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001547371 issn: 2352-5126 databaseCode: DOA dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2352-5126 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001547371 issn: 2352-5126 databaseCode: M~E dateStart: 20150101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWgQogL4pvwUQWJG4qI7TQZHwG14tIKqSDtzfInpKLZVdNF4sJvZyZOog2g9sJlD9k4Vl6eM2-U8RvGXisvvOGlKWLAx1BZFQsQBgpvwDSooMFCHJpNNCcnsFqpTzutvqgmLNkDJ-DeNjbWgGEsgoNK2mBLC8aE0mGodqgM6e2LqmcnmUr7g6tGDtmWQIVRYFSrxx0zqbjrzDsyAxUyeXaKRVQazPsXwelv8flnDeVOUDq6x-6OajJ_l-7iPrsRugfs9vH4vfwhk6ebgORqz43Nt33I2y6fK8vzdcw3P6kV2rnJv5oOE-9ujbx8xL4cHX7-8LEY2yQU7qCSolAAzggeZXCN5wYVF8o6F6yzMTjFJUSM6ZWsuZNRUjrlrWxcWXtuSx8dyMdsr1t34SnLa6iiisZR85oKL2CUAy-5H6Rfo1TG-ASTdqOHOLWy-K6nYrEzTdBqglaXXCO0GXszj9kkB40rz35P6M9nkvv1cAA5oUdO6Os4kTE5PTs9bTDFVyJeqL1y6uZfo0I_rupec90LXepT4hRRCtM38vepM3YwjxyFSxIk1874aiKWxlVNn2pMF9bbXgsq8sRUVJQZe5KINkMiayVrqHFWWFBwgdnyn679NjiHk-EWKexn_wPl5-wO3UsqY3rB9i4vtuElu-V-XLb9xT672axgf1iV-Hv86_A31io6dg |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Spesolimab+use+in+treatment+of+pyoderma+gangrenosum&rft.jtitle=JAAD+Case+Reports&rft.au=Gu%C3%A9nin%2C+Sophie+H.&rft.au=Khattri%2C+Saakshi&rft.au=Lebwohl%2C+Mark+G.&rft.date=2023-04-01&rft.pub=Elsevier&rft.eissn=2352-5126&rft.volume=34&rft.spage=18&rft.epage=22&rft_id=info:doi/10.1016%2Fj.jdcr.2023.01.022&rft.externalDocID=PMC10015112 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F23525126%2FS2352512623X00034%2Fcov150h.gif |